Clancy CE - Search Results

1

Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening.

Moreno JD, Yang PC, Bankston JR, Grandi E, Bers DM, Kass RS, Clancy CE. Moreno JD, et al. Among authors: clancy ce. Circ Res. 2013 Sep 13;113(7):e50-e61. doi: 10.1161/CIRCRESAHA.113.301971. Epub 2013 Jul 29. Circ Res. 2013. PMID: 23897695 Free PMC article.

2

Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.

Liu H, Tateyama M, Clancy CE, Abriel H, Kass RS. Liu H, et al. Among authors: clancy ce. J Gen Physiol. 2002 Jul;120(1):39-51. doi: 10.1085/jgp.20028558. J Gen Physiol. 2002. PMID: 12084774 Free PMC article.

3

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.

Splawski I, Timothy KW, Tateyama M, Clancy CE, Malhotra A, Beggs AH, Cappuccio FP, Sagnella GA, Kass RS, Keating MT. Splawski I, et al. Among authors: clancy ce. Science. 2002 Aug 23;297(5585):1333-6. doi: 10.1126/science.1073569. Science. 2002. PMID: 12193783

4

A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.

Rivolta I, Clancy CE, Tateyama M, Liu H, Priori SG, Kass RS. Rivolta I, et al. Among authors: clancy ce. Physiol Genomics. 2002 Sep 3;10(3):191-7. doi: 10.1152/physiolgenomics.00039.2002. Physiol Genomics. 2002. PMID: 12209021

5

Defective cardiac ion channels: from mutations to clinical syndromes.

Clancy CE, Kass RS. Clancy CE, et al. J Clin Invest. 2002 Oct;110(8):1075-7. doi: 10.1172/JCI16945. J Clin Invest. 2002. PMID: 12393842 Free PMC article. Review. No abstract available.

6

Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.

Clancy CE, Tateyama M, Kass RS. Clancy CE, et al. J Clin Invest. 2002 Nov;110(9):1251-62. doi: 10.1172/JCI15928. J Clin Invest. 2002. PMID: 12417563 Free PMC article.

7

K+ channel structure-activity relationships and mechanisms of drug-induced QT prolongation.

Clancy CE, Kurokawa J, Tateyama M, Wehrens XH, Kass RS. Clancy CE, et al. Annu Rev Pharmacol Toxicol. 2003;43:441-61. doi: 10.1146/annurev.pharmtox.43.100901.140245. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12540747 Review.

8

Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.

Clancy CE, Tateyama M, Liu H, Wehrens XH, Kass RS. Clancy CE, et al. Circulation. 2003 May 6;107(17):2233-7. doi: 10.1161/01.CIR.0000069273.51375.BD. Epub 2003 Apr 14. Circulation. 2003. PMID: 12695286

9

Mutations in cardiac sodium channels: clinical implications.

Liu H, Clancy C, Cormier J, Kass R. Liu H, et al. Am J Pharmacogenomics. 2003;3(3):173-9. doi: 10.2165/00129785-200303030-00003. Am J Pharmacogenomics. 2003. PMID: 12814325 Review.

10

Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation.

Tateyama M, Rivolta I, Clancy CE, Kass RS. Tateyama M, et al. Among authors: clancy ce. J Biol Chem. 2003 Nov 21;278(47):46718-26. doi: 10.1074/jbc.M308977200. Epub 2003 Sep 18. J Biol Chem. 2003. PMID: 14500710 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters